BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27504928)

  • 1. Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.
    Hartwell EE; Moallem NR; Courtney KE; Glasner-Edwards S; Ray LA
    J Addict Med; 2016; 10(6):395-401. PubMed ID: 27504928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between methamphetamine use and increased dental disease.
    Shetty V; Mooney LJ; Zigler CM; Belin TR; Murphy D; Rawson R
    J Am Dent Assoc; 2010 Mar; 141(3):307-18. PubMed ID: 20194387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.
    Rungnirundorn T; Verachai V; Gelernter J; Malison RT; Kalayasiri R
    J Addict Med; 2017; 11(1):19-27. PubMed ID: 27649265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine use by incarcerated women: comorbid mood and anxiety problems.
    Vik PW
    Womens Health Issues; 2007; 17(4):256-63. PubMed ID: 17544297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 7. Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: an emerging profile.
    von MC; Brecht ML; Anglin MD
    J Addict Dis; 2002; 21(1):45-60. PubMed ID: 11831499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use.
    Ma J; Sun XJ; Wang RJ; Wang TY; Su MF; Liu MX; Li SX; Han Y; Meng SQ; Wu P; Shi J; Bao YP; Lu L
    Psychiatry Res; 2018 Apr; 262():184-192. PubMed ID: 29453037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of drug craving over time in abstinent methamphetamine users.
    Galloway GP; Singleton EG; Buscemi R; Baggott MJ; Dickerhoof RM; Mendelson JE;
    Am J Addict; 2010; 19(6):510-4. PubMed ID: 20958846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality traits and mental health states of methamphetamine-dependent and methamphetamine non-using MSM.
    Solomon TM; Kiang MV; Halkitis PN; Moeller RW; Pappas MK
    Addict Behav; 2010 Feb; 35(2):161-3. PubMed ID: 19786324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soda Consumption Among Methamphetamine Users in the USA: Impact on Oral Health.
    Murphy DA; Harrell L; Fintzy R; Vitero S; Gutierrez A; Shetty V
    Oral Health Prev Dent; 2016; 14(3):227-34. PubMed ID: 26870851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: An ERP study.
    Wang D; Zhou C; Chang YK
    Physiol Behav; 2015 Aug; 147():38-46. PubMed ID: 25846839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
    Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craving and control: methamphetamine users' narratives.
    Bruehl AM; Lende DH; Schwartz M; Sterk CE; Elifson K
    J Psychoactive Drugs; 2006 Nov; Suppl 3():385-92. PubMed ID: 17357530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.
    Kheirabadi GR; Bahrami M; Shariat A; Tarrahi M
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):45-48. PubMed ID: 33347022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between impulsivity and methamphetamine use severity in a community sample.
    Moallem NR; Courtney KE; Ray LA
    Drug Alcohol Depend; 2018 Jun; 187():1-7. PubMed ID: 29626740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in methamphetamine use and responses: a review.
    Dluzen DE; Liu B
    Gend Med; 2008 Mar; 5(1):24-35. PubMed ID: 18420163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.
    Obermeit LC; Cattie JE; Bolden KA; Marquine MJ; Morgan EE; Franklin DR; Atkinson JH; Grant I; Woods SP;
    Addict Behav; 2013 Dec; 38(12):2874-8. PubMed ID: 24018233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between psychiatric symptoms and craving in methamphetamine users.
    Nakama H; Chang L; Cloak C; Jiang C; Alicata D; Haning W
    Am J Addict; 2008; 17(5):441-6. PubMed ID: 18770088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.